NCT05631795 2026-04-07
ALPINIST
Novartis
Phase 4 Completed
Clinical Trials
13 trialsNCT06353529 2026-03-12
POPPY
Hamilton Health Sciences Corporation
Phase 4 Recruiting
NCT04373564 2026-01-22
ODYSSEY
Guerbet
Phase 4 Recruiting
NCT07354698 2026-01-21
MHI
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 4 Not yet recruiting
NCT07272512 2025-12-19
ZSPAC-17
Shanghai Zhongshan Hospital
Phase 4 Recruiting
NCT06016855 2025-12-17
Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Vanderbilt-Ingram Cancer Center
Phase 4 Recruiting
NCT04081701 2025-11-21
DOMINO-START
Weill Medical College of Cornell University
Phase 4 Recruiting
NCT06195228 2025-08-14
A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
Fudan University
Phase 4 Recruiting
NCT07034859 2025-06-24
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
National Taiwan University Hospital
Phase 4 Enrolling by invitation
NCT05702944 2025-06-12
The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma
Seoul National University Hospital
Phase 4 Recruiting
NCT07014540 2025-06-11
A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma
Beijing GoBroad Hospital
Phase 4 Not yet recruiting
NCT05822817 2025-06-08
Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery
Peking Union Medical College Hospital
Phase 4 Completed
NCT03289741 2025-05-09
A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide
Memorial Sloan Kettering Cancer Center
Phase 4 Completed